Latest Stories
Uncategorized
AstraZeneca Signs Up to $1.5 Billion AI Drug-Discovery Deal With insitro to Target MASH and Cardiomyopathies
AstraZeneca signed an AI drug-discovery deal with insitro on October 15, 2026 worth up to $1.5 billion, targeting MASH and cardiomyopathies using insitro's Virtual Human machine-learning platform.
Uncategorized
Chai Discovery Raises $400 Million at $3.8 Billion Valuation as AI Drug Design Reaches Eli Lilly and Pfizer
Chai Discovery has raised a $400 million Series C round led by Index Ventures at a $3.8 billion valuation, nearly tripling its worth from seven months earlier as its AI-designed antibodies move into partnerships with Eli Lilly and Pfizer.
Uncategorized
OpenAI Acquires Health-Tech Startup Torch to Build ‘Unified Medical Memory’ for ChatGPT Health
OpenAI has acquired Torch, a four-person health-tech startup building a unified patient data layer for AI systems, in a deal reported at $60 million to $100 million as part of its push into consumer health products.
Uncategorized
University of Texas System to Deploy Generative AI Across All Health Institutions With Qualified Health
The University of Texas System is rolling out a generative AI chat platform and staff productivity agents across its health institutions in partnership with Qualified Health, one of the broadest academic-medicine AI deployments announced in 2026.
In-Depth
Uncategorized
AstraZeneca and Oracle Launch Global AI Collaboration to Speed Clinical Trials and Early Diagnosis
AstraZeneca and Oracle announced a global AI collaboration on October 20, 2026 to speed clinical trial recruitment and early diagnosis, starting with a hypertension pilot in Abu Dhabi built on deidentified real-world data.
Uncategorized
Swedish MASAI Trial Finds AI-Supported Mammography Catches More Cancers Without More False Alarms
Sweden's randomized MASAI trial found AI-supported mammography improved detection of clinically relevant breast cancers without raising false-positive rates, bolstering the evidence base for AI-assisted screening.
Uncategorized
New AI Model Automates Cervical Cancer Screening Reads Across 9,000-Plus Slides
A new AI system called Cytoreader-Fusion automated dual-stain cervical cancer screening reads across more than 9,000 slides in a retrospective study, part of a broader wave of AI cancer-screening research in 2026.
Uncategorized
UpDoc’s FDA Clearance Opens the Door for AI That Talks Directly to Patients
UpDoc's June FDA clearance as a patient-facing large language model opened new regulatory territory for AI that interacts directly with patients, a precedent other companies are now racing to replicate.
Uncategorized
FDA’s AI-Enabled Medical Device List Tops 1,600, With Clearances on Pace to Set a New Record
The FDA's list of authorized AI-enabled medical devices passed 1,600 in September, with 2026 clearances on pace to set a new annual record, even as the agency says its own list likely undercounts the true total.
